Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies
5
Zitationen
10
Autoren
2022
Jahr
Abstract
Abstract The coronavirus disease 2019 (COVID-19) pandemic resulted in severe interruptions to clinical research worldwide. This global public health crisis required investigators and researchers to rapidly develop and implement new strategies and solutions to mitigate its negative impact on the progress of clinical trials. In this paper, we describe the challenges, strategies, and lessons learned regarding the continuation of a supportive oncology clinical trial during the pandemic. We hope to provide insight into the implementation of clinical trials during a public health emergency to be better prepared for future instances. Trial registration: ClinicalTrials.gov, a service of the US National Institute of Health (NCT 03030859). Registered on 22 January 2017.
Ähnliche Arbeiten
Clinical Characteristics of Coronavirus Disease 2019 in China
2020 · 31.040 Zit.
Cancer statistics, 2023
2023 · 16.248 Zit.
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
2020 · 9.843 Zit.
Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019
2020 · 8.228 Zit.
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
2018 · 7.664 Zit.